This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing OASIS 1 and 2 Phase III studies of Bayer's elinzanetant in treating VMS associated with menopause
Ticker(s): BAYRYWho's the expert?
Institution: Private Practice
- Board-certified internist and midlife women's health expert who has practiced in both academics and private practice since 1991
- Manages 250 patients with menopause.
- Dr. Larkin has been practicing internal medicine and women's health care within Concierge Medicine of Cincinnati, a multispecialty internal medicine and women's health specialty practice she independently launched, and a practice she has grown over to 3 locations employing 10 providers.
Interview GoalThis interview will focus on Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
